Best GLP-1 Weight Loss Program in Bangalore | TODS India
Doctor-Supervised · Evidence-Based · Bangalore

Best GLP-1 Weight Loss Program in Bangalore

At Dr. Tulip's Obesity & Diabetes Surgery Centre (TODS), we have built one of Bangalore's most comprehensive GLP-1 weight loss programmes around safety, personalisation, and long-term metabolic health — not quick fixes.

14.9%
Average body weight reduction
with Semaglutide — STEP-1 Trial, NEJM 2021
20.9%
Average weight reduction
with Tirzepatide — SURMOUNT-1 Trial
68 wks
Duration of landmark
clinical trial programmes
If you have been searching for a medically sound, doctor-supervised GLP-1 weight loss programme in Bangalore, you are certainly not alone. In clinics across the city — from Koramangala and JP Nagar to Whitefield and Indiranagar — more and more patients are asking about GLP-1 injections like Mounjaro (Tirzepatide) and Ozempic (Semaglutide) as a safe, evidence-based alternative to fad diets and crash programmes.

GLP-1 receptor agonists have fundamentally changed how obesity is treated worldwide. But their effectiveness is inseparable from proper medical oversight. This is exactly where a structured, doctor-led programme makes all the difference.
Section 01

What Is a GLP-1 Weight Loss Programme?

A GLP-1 weight loss programme is a structured medical intervention that uses glucagon-like peptide-1 (GLP-1) receptor agonist medications — such as Semaglutide (Ozempic/Wegovy) or Tirzepatide (Mounjaro) — alongside diet counselling, metabolic monitoring, and regular physician reviews to help patients achieve meaningful, sustained weight loss.

Unlike over-the-counter diet supplements or generic slimming clinics, a proper GLP-1 programme begins with a thorough medical evaluation: blood tests, cardiovascular screening, HbA1c, fasting insulin, thyroid function, liver enzymes, and body composition analysis. The medication dose is then titrated gradually — starting low and moving up only when it is safe and well-tolerated.

The 'programme' aspect is critical. GLP-1 medications are powerful tools, but they work best when paired with nutritional guidance, physical activity support, and a physician who understands your metabolic history. Without that structure, patients risk poor dosing, unmanaged side effects, or weight regain once medication stops.

GLP-1 medical treatment
A proper GLP-1 programme begins with a thorough medical evaluation — blood tests, cardiovascular screening, and body composition analysis
14.9%
Average body weight reduction with Semaglutide over 68 weeks
STEP-1 Trial · NEJM 2021
20.9%
Average weight reduction with Tirzepatide in some trial arms
SURMOUNT-1 Trial
5–15%
Typical body weight reduction over 6–12 months in real-world supervised programmes
Clinical practice estimates
Section 02

How GLP-1 Medications Work

Healthy nutrition and metabolic health
Metabolic improvements in HbA1c, blood pressure, and liver fat often occur well before dramatic weight changes

GLP-1 is a natural gut hormone released after eating. It signals the brain to reduce appetite, slows the rate at which food leaves the stomach (gastric emptying), and improves insulin sensitivity. GLP-1 receptor agonists mimic this hormone — but with a longer duration of action than the body's own GLP-1.

The result is that patients feel full sooner, eat less, experience fewer cravings — particularly for high-calorie processed foods — and, over time, lose meaningful body weight.

In landmark clinical trials, semaglutide (STEP-1, NEJM 2021) produced an average body weight reduction of approximately 14.9% over 68 weeks. Tirzepatide (SURMOUNT-1) produced even greater average reductions — up to 20.9% in some arms of the trial.

These outcomes are comparable to results seen with metabolic surgery in carefully selected patients, making GLP-1 therapy one of the most significant developments in non-surgical obesity medicine in decades.

Section 03

Mounjaro vs. Ozempic — A Quick Comparison

Both medications belong to the GLP-1 class but differ in mechanism. Your doctor at TODS will recommend the most appropriate option based on your medical profile, metabolic markers, existing conditions, and treatment goals. Cost is also a practical consideration.

Greater Avg. Weight Loss
Dual GLP-1 + GIP Agonist

Mounjaro

Tirzepatide · Eli Lilly
From ₹3,281 per weekly injection (as of mid-2026)

Mounjaro activates two metabolic hormone pathways simultaneously — both GLP-1 and GIP receptor pathways. In head-to-head clinical data, Tirzepatide consistently produces greater average weight loss than Semaglutide. Both are available at TODS.

Pure GLP-1 Agonist

Ozempic

Semaglutide · Novo Nordisk · Also: Wegovy
From ₹1,415 per weekly injection · Generic options from ₹325/week

Ozempic is a pure GLP-1 receptor agonist with robust clinical evidence. Generic Semaglutide options are now available in India from approximately ₹325 per weekly injection — though medical supervision remains equally important regardless of brand prescribed.

* Prices are indicative and subject to change. Programme fees — which include consultations, monitoring, and follow-up — are separate and discussed at your assessment.

Section 04

Who Is a Good Candidate?

GLP-1 therapy is generally appropriate for adults with a BMI of 27.5 or above (the threshold used for South Asian populations). Eligibility is determined through a comprehensive consultation — not a quick online form. A full contraindication review is part of every TODS assessment.

You may be a good candidate if…

  • BMI of 27.5 or above with at least one weight-related comorbidity
  • Diagnosis of type 2 diabetes, hypertension, dyslipidaemia, or sleep apnoea
  • Fatty liver disease (NAFLD)
  • BMI of 32.5 or above, even without a comorbidity (pending clinical assessment)
  • Adult patient committed to lifestyle changes during treatment

GLP-1 medications are not appropriate if…

  • Personal or family history of medullary thyroid carcinoma
  • Multiple Endocrine Neoplasia type 2 (MEN2)
  • Severe gastrointestinal disease
  • History of pancreatitis
  • Currently pregnant or planning pregnancy
Section 05

What Does the TODS Programme Look Like?

Our four-step programme is built around safety, personalisation, and long-term metabolic health. Every patient is seen, assessed, and managed by qualified physicians committed to evidence-based care.

1

Comprehensive Medical Assessment

Full blood panel, body composition scan, cardiovascular risk profiling, dietary history, and metabolic evaluation by a senior physician. This takes place at our centre, easily accessible from South Bangalore areas including JP Nagar, Banashankari, and Jayanagar.

2

Personalised Treatment Plan

Based on your assessment, we determine whether Semaglutide or Tirzepatide is more appropriate, what your starting dose should be, and what your titration schedule will look like over the following weeks.

3

Ongoing Monitoring

Monthly reviews include weight, blood pressure, blood glucose, side-effect assessment, and dietary adherence. Dosing adjustments are made by the physician — never left to the patient to self-manage without guidance.

4

Long-Term Planning

We discuss what happens at the end of active therapy — weight maintenance strategies, lifestyle anchoring, and the evidence around medication duration — so that every patient has a realistic roadmap beyond the injection phase.

Doctor consultation at TODS
Every step managed by qualified obesity medicine physicians at TODS, South Bangalore
Section 06

Why Bangalore Patients Choose TODS

TODS was founded by Dr. Tulip, one of Bangalore's most respected obesity and metabolic surgery specialists. Unlike clinics that have recently added GLP-1 therapy as a side service, TODS was built around obesity medicine from the ground up. Every aspect of our programme — from diagnostic protocols to follow-up structure — reflects clinical best practice.

We are not a weight loss spa. We are not a gym with a doctor on call. We are a dedicated obesity medicine centre where every patient is seen, assessed, and managed by qualified physicians committed to evidence-based care.

🏥

Built for Obesity Medicine

TODS was built around obesity medicine from the ground up — not a side service. Every protocol reflects clinical best practice.

🕐

Flexible Scheduling

IT professionals from Whitefield and Electronic City get flexible appointment times. Working professionals from HSR Layout and BTM Layout get a programme that fits demanding schedules.

💬

Plain-Language Care

Homemakers from Rajajinagar and Malleshwaram find a doctor who speaks plainly about treatment options — no jargon, no pressure.

🔬

Evidence-Based Protocols

Every decision — from initial assessment to dose titration to exit planning — is grounded in peer-reviewed clinical evidence.

📊

Continuous Monitoring

Monthly reviews track weight, blood pressure, blood glucose, and dietary adherence. Adjustments are made by physicians, not algorithms.

🗺️

Long-Term Roadmap

Every patient leaves with a realistic plan beyond the injection phase — maintenance strategies, lifestyle anchoring, and exit planning built in.

Section 07

Risks, Side Effects, and What to Watch For

GLP-1 medications are well tolerated by most patients, particularly when doses are titrated gradually. The most common side effects are gastrointestinal in nature: nausea, vomiting, constipation, or diarrhoea. These are generally mild and transient, and tend to improve after the first few weeks.

Rare but serious considerations include pancreatitis, gallbladder disease, and — in theoretical animal models — thyroid C-cell effects (the clinical relevance in humans is still under study). This is precisely why a proper medical evaluation before starting treatment, and regular monitoring during it, is not optional — it is essential.

Common side effects (most are mild & transient)

Nausea — very common, usually mild
Vomiting — common, typically transient
Constipation
Diarrhoea
Pancreatitis — rare but serious
Gallbladder disease — rare
Thyroid C-cell effects (under study in humans)
⚠ Important Safety Notice
At TODS, our doctors provide detailed pre-treatment counselling so that patients know exactly what to expect, when to contact the clinic, and when a symptom warrants early review. Self-medicating with GLP-1 injections purchased online — without evaluation or monitoring — is something we strongly advise against.
Medical monitoring and care
Regular physician-led monitoring ensures your safety and optimises results throughout the programme
Section 08

Real-World Outcomes: What to Expect

Clinical trial results are an average across large populations. In practice, individual weight loss varies. Most patients in a well-supervised programme can expect 5–15% body weight reduction over 6–12 months, with the higher end of that range more achievable with Tirzepatide in adherent patients.

⚖️
Weight Loss: 5–15% body weight over 6–12 months

The higher end of this range is more achievable with Tirzepatide in adherent patients. Results depend on starting weight, metabolic profile, lifestyle adherence, and medication choice.

🩸
Improved HbA1c and Blood Glucose Control

Meaningful improvements in blood sugar levels are often among the earliest benefits seen — particularly important for patients with type 2 diabetes or prediabetes.

❤️
Lower Blood Pressure and Improved Lipids

Cardiovascular risk markers frequently improve significantly, often well before the most dramatic weight changes occur.

🫁
Reduced Liver Fat and Better Sleep Quality

Patients with fatty liver disease (NAFLD) and sleep apnoea often see meaningful functional improvements — outcomes that are personally significant beyond the numbers on a scale.

"We do not guarantee specific weight loss results — no ethical clinic does. What we guarantee is that our programme is built on science, delivered with care, and reviewed continuously by doctors who understand obesity as the complex metabolic condition it is."

— TODS Medical Team
Section 09

Frequently Asked Questions

Everything you need to know about GLP-1 therapy, eligibility, costs, and what to expect at TODS.

Is GLP-1 therapy available in Bangalore?
Yes. Mounjaro (Tirzepatide) and Ozempic (Semaglutide) are both available in Bangalore under doctor supervision. At TODS, we have a structured medical programme for eligible patients. Both medications are prescribed following a thorough medical assessment at our centre.
How much does a GLP-1 programme cost in Bangalore?
Costs depend on the medication chosen, dosage, and duration. Mounjaro starts at approximately ₹3,281 per weekly injection and Ozempic from approximately ₹1,415 per week. Generic Semaglutide options are also available from around ₹325 per week. Programme fees are separate and include consultations, monitoring, and follow-up. Please book an assessment for a personalised cost breakdown.
Do I need a prescription for Mounjaro or Ozempic?
Yes. Both are prescription medications and should only be started after a medical evaluation. Obtaining them without a proper assessment significantly increases the risk of adverse effects, including poor dosing, unmanaged side effects, and lack of monitoring for rare but serious complications.
How long do I need to be on GLP-1 medication?
Duration depends on your health goals and response to treatment. Many patients use GLP-1 therapy for 12–24 months. Long-term use is being studied in ongoing clinical trials. Your TODS physician will review duration as part of your ongoing plan, and will discuss a realistic roadmap for when and how to stop.
Will I regain weight when I stop?
Some weight regain is common after stopping GLP-1 medications, as the medication's appetite-suppressing effect diminishes. This is why lifestyle changes built during treatment are critical to long-term maintenance. Your TODS programme includes exit planning for this reason — we don't just manage medication, we help you build lasting habits.
Is the TODS clinic easily accessible from Koramangala or Whitefield?
Yes. TODS is located in South Bangalore and is accessible by major road networks from Koramangala, HSR Layout, JP Nagar, Electronic City, Whitefield, and other areas across the city. We also offer flexible appointment scheduling to minimise wait times and accommodate working professionals.
Who qualifies for GLP-1 therapy at TODS?
GLP-1 therapy is generally appropriate for adults with a BMI of 27.5 or above who also have at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidaemia, sleep apnoea, or fatty liver disease (NAFLD). Patients with a BMI of 32.5 or above may also be candidates even without a comorbidity, depending on clinical assessment. Certain contraindications must be ruled out — including history of medullary thyroid carcinoma, MEN2, pancreatitis, severe GI disease, or pregnancy.
Section 10

Serving All of Bangalore

TODS serves patients across Bangalore — including JP Nagar, Jayanagar, Koramangala, BTM Layout, HSR Layout, Electronic City, Marathahalli, Whitefield, Indiranagar, Banashankari, Rajajinagar, Malleshwaram, Yelahanka, and Hebbal.

Whether you are a busy professional from the tech corridor or a resident of South Bangalore's residential neighbourhoods, we offer flexible consultation scheduling designed around your life.

JP Nagar Jayanagar Koramangala BTM Layout HSR Layout Electronic City Marathahalli Whitefield Indiranagar Banashankari Rajajinagar Malleshwaram Yelahanka Hebbal
Bangalore city
Accessible from across Bangalore — South, North, East & West — with flexible appointment times
Medical Review

⚕ Medical Review Notice

This article has been reviewed for clinical accuracy by the medical team at Dr. Tulip's Obesity & Diabetes Surgery Centre. The information provided is for educational purposes and does not constitute personalised medical advice. Please consult a qualified physician before beginning any weight loss programme.

Dr
✓ Medically Reviewed

Dr. Tulip

MS, FMAS, FIAGES — Senior Bariatric & Metabolic Surgeon, TODS India

Specialist in Obesity Medicine, Bariatric Surgery, and Metabolic Health — TODS India, Bangalore. Dr. Tulip is one of Bangalore's most respected obesity and metabolic surgery specialists, with deep expertise in non-surgical obesity interventions including GLP-1 therapy, alongside surgical options for eligible patients.

Ready to Find Out If a GLP-1 Programme Is Right for You?

Book a comprehensive medical assessment at TODS today. Our team will evaluate your health profile, explain your options, and build a personalised plan — with no pressure and full transparency.